Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „selpercatinib“
Suchtreffer
Begriffe & Kennungen
Retsevmo · 4.5 · Agents that may decrease selpercatinib plasma concentrations Co-administration of rifampicin, a strong CYP3A4
Eintrag öffnenRetsevmo · 4.5 · Agents that may decrease selpercatinib plasma concentrations Co-administration of rifampicin, a strong CYP3A4
Eintrag öffnenRetsevmo · 4.5 · Agents that may increase selpercatinib plasma concentrations Co-administration of a single 160 mg selpercatini
Eintrag öffnenRetsevmo · 4.5 · Agents that may increase selpercatinib plasma concentrations Co-administration of a single 160 mg selpercatini
Eintrag öffnenRetsevmo · 4.5 · Co-administration with multiple daily doses of omeprazole (a proton pump inhibitor) decreased selpercatinib AU
Eintrag öffnenRetsevmo · 4.5 · Co-administration with multiple daily doses of omeprazole (a proton pump inhibitor) decreased selpercatinib AU
Eintrag öffnenRetsevmo · 4.5 · Effects of other medicinal products on the pharmacokinetics of selpercatinib
Eintrag öffnenRetsevmo · 4.5 · Effects of other medicinal products on the pharmacokinetics of selpercatinib
Eintrag öffnenRetsevmo · 4.5 · Effects of selpercatinib on the pharmacokinetics of other medicinal products (increase in plasma concentration
Eintrag öffnenRetsevmo · 4.5 · Effects of selpercatinib on the pharmacokinetics of other medicinal products (increase in plasma concentration
Eintrag öffnenRetsevmo · 4.5 · Medicinal products that may be less effective when given with selpercatinib
Eintrag öffnenRetsevmo · 4.5 · Medicinal products that may be less effective when given with selpercatinib
Eintrag öffnenRetsevmo · 4.5 · Selpercatinib could inhibit D2 deiodinase and thereby decrease the conversion of levothyroxine (T4) to triiodo
Eintrag öffnenRetsevmo · 4.5 · Selpercatinib could inhibit D2 deiodinase and thereby decrease the conversion of levothyroxine (T4) to triiodo
Eintrag öffnenRetsevmo · 4.5 · Selpercatinib has pH-dependent solubility, with decreased solubility at higher pH. No clinically significant d
Eintrag öffnenRetsevmo · 4.5 · Selpercatinib has pH-dependent solubility, with decreased solubility at higher pH. No clinically significant d
Eintrag öffnenRetsevmo · 4.5 · Selpercatinib inhibits the renal transporter multidrug and toxin extrusion protein 1 (MATE1). In vivo interact
Eintrag öffnenRetsevmo · 4.5 · Selpercatinib inhibits the renal transporter multidrug and toxin extrusion protein 1 (MATE1). In vivo interact
Eintrag öffnenRetsevmo · 4.5 · Selpercatinib is a substrate for P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP) in vitro, h
Eintrag öffnenRetsevmo · 4.5 · Selpercatinib is a substrate for P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP) in vitro, h
Eintrag öffnen